VANGUARD GROUP INC 13D and 13G filings for Collegium Pharmaceutical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | Collegium Pharmaceutical, Inc. COLL | VANGUARD GROUP INC | 2,312,786 7.090% | 104,675![]() (+4.74%) | Filing |
2023-02-09 11:16 am Sale | 2022-12-30 | 13G | Collegium Pharmaceutical, Inc. COLL | VANGUARD GROUP INC | 2,208,111 6.580% | -79,306![]() (-3.47%) | Filing |
2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | VANGUARD GROUP INC | 2,287,417 6.620% | 556,565![]() (+32.16%) | Filing |
2021-02-10 10:46 am Purchase | 2020-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | VANGUARD GROUP INC | 1,730,852 5.010% | 50,198![]() (+2.99%) | Filing |